 Amphastar Pharmaceuticals has several key growth drivers: a strong pipeline of products currently awaiting approval, exciting products with growing sales, and growing marketing and distribution channels. With approvals for its developed products pending, AMPH could anticipate doubling its revenues if it can obtain those approvals on time. 